4.5 Article

Contribution of Intravenous Administration Components to Subvisible and Submicron Particles Present in Administered Drug Product

期刊

JOURNAL OF PHARMACEUTICAL SCIENCES
卷 108, 期 7, 页码 2406-2414

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.xphs.2019.02.020

关键词

biopharmaceutical characterization; injectable(s); microparticle(s); nanoparticle(s); particle size; physical characterization

资金

  1. Pfizer, Inc.

向作者/读者索取更多资源

Particulate matter present in drug products intended for parenteral administration to patients is typically monitored and controlled in the finished drug product to minimize potential risks to patients. In contrast to particulates found in drug products, the current study evaluated particulates representative of materials and operations typically used in the dose preparation and administration of drug products. A comprehensive assessment of intrinsic and extrinsic sources of subvisible and submicron particulates arising from materials associated with subcutaneous and intravenous dose preparation and administration was conducted. In particular, particles arising from disposable syringes, commercial sterile diluents, and intravenous supplies were quantitated using established methods for subvisible (ilight obscuration, flow imaging) and submicron particles (iresistive pulse sensing). Each of these sources contributed varying amounts of particulates; therefore, owing to sources from materials required for administration, it is inadequate to assume that the total particulate load delivered to patients arises solely from the drug product. Careful consideration of the administration method and supplies used can improve the predictability of particulate levels present in dose preparations or administration volumes. (c) 2019 American Pharmacists Association (R). Published by Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据